Health & Artificial Intelligence

Issue 43 l Eka’s thesis on Health & AI

We’ve been busy for the past 6 months, speaking to 50+ experts on how Artificial Intelligence is going to change Healthcare. Today, we’re publishing our report on Health and Artificial Intelligence. If you’re a founder building in the space, we’d love to speak with you.

Artificial Intelligence (AI) is changing the world. It has the potential to catalyse the structural change that the healthcare system needs to be able to serve a growing and ageing population. The companies that enable this change will capture significant economic value, with healthcare spend making up 10% of the World’s GDP. 

At Eka, we strongly believe that AI will play a core role in shifting the healthcare system from a reactive, treatment based model to a proactive and preventative system. 95% of healthcare spend is on treatment rather than prevention, but the quality of the treatment received only determines 20% of your health.

As a TLDR, the report covers:

• Market map: 3,000 global companies playing in the Health & AI space, and our spotlight on the UK early-stage players.

• Startup vs. Incumbents: Pitting the big tech incumbents against early-stage players on where there is value to be made.

• Commoditisation in Healthcare: Understanding why healthcare is different to other generalist LLMs.

• Regulation Spotlight: Unpacking the key regulatory milestones including the EU’s Artificial Intelligence Act, UK’s Software as a Medical Device, and US’s Blueprint for AI Bill of Rights.

• Companies of Tomorrow: Drawing up our view of what the largest health companies of tomorrow will look like: (1) Consumer application which merges 

  prevention & diagnostics, and (2) Primary care infrastructure platform enabling the best clinical outcomes.

The early-stage UK players in Health and Artificial Intelligence…

… why Startups have the potential to create value in health…

… and what tomorrow’s companies will look like

To access the full report - click here.